# Sugammadex After Continuous Infusion of Rocuronium During Sevoflurane and Propofol Anesthesia (P05949; MK-8616-028)

> **NCT00559468** · PHASE3 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 52 (actual)

## Conditions studied

- Anesthesia, General

## Interventions

- **DRUG:** Sugammadex
- **DRUG:** Rocuronium
- **DRUG:** Sevoflurane
- **DRUG:** Propofol

## Key facts

- **NCT ID:** NCT00559468
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12-07
- **Primary completion:** 2007-03-02
- **Final completion:** 2007-03-02
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2019-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00559468

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00559468, "Sugammadex After Continuous Infusion of Rocuronium During Sevoflurane and Propofol Anesthesia (P05949; MK-8616-028)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00559468. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*